Dr. Andrea D. Sullivan urges Americans to rethink the Ozempic craze and address the root cause: a lack of education about food and lifestyle. The real epidemic is our disconnection from food—what we ...

According to new research, having an afternoon cup of coffee might seem harmless—but caffeine continues to affect the body, ...

Wondering how to feel about Ozempic? These unexpected questions help reveal what may really be driving your reaction and how ...

We have recently begun acquiring a new position in Novo Nordisk. Click here for our investment thesis on NVO stock.

New research links semaglutide and tirzepatide, which are GLP-1 agonists used to treat type 2 diabetes and aid weight loss, ...

GDS’s June insights covers Buffett’s legacy, Novo’s rebound, and Rivian’s rise. Click here to read the full note now.